<!DOCTYPE html>

<html class="client-nojs" dir="ltr" lang="en">
<head>
<meta charset="utf-8"/>
<title>NK-92 - Wikipedia</title>
<script>document.documentElement.className = document.documentElement.className.replace( /(^|\s)client-nojs(\s|$)/, "$1client-js$2" );</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"NK-92","wgTitle":"NK-92","wgCurRevisionId":890886148,"wgRevisionId":890886148,"wgArticleId":39124671,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles that may contain original research from April 2013","All articles that may contain original research","Articles lacking in-text citations from April 2013","All articles lacking in-text citations","Articles with a promotional tone from April 2013","All articles with a promotional tone","Wikipedia articles with possible conflicts of interest from April 2013","Articles with multiple maintenance issues","All articles with unsourced statements","Articles with unsourced statements from April 2019","All articles with vague or ambiguous time","Vague or ambiguous time from March 2019","Articles with unsourced statements from March 2019","All articles with specifically marked weasel-worded phrases","Articles with specifically marked weasel-worded phrases from March 2019","Human cell lines","Cancer treatments","Biotechnology","Genetic engineering"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"NK-92","wgRelevantArticleId":39124671,"wgRequestId":"XL9veQpAIC4AAJIRfG8AAAAX","wgCSPNonce":false,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgFlaggedRevsParams":{"tags":{}},"wgStableRevisionId":null,"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsReferencePreviews":false,"wgPopupsConflictsWithNavPopupGadget":false,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en","usePageImages":true,"usePageDescriptions":true},"wgMFDisplayWikibaseDescriptions":{"search":true,"nearby":true,"watchlist":true,"tagline":false},"wgRelatedArticles":null,"wgRelatedArticlesUseCirrusSearch":true,"wgRelatedArticlesOnlyUseCirrusSearch":false,"wgWMESchemaEditAttemptStepOversample":false,"wgPoweredByHHVM":true,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgCentralNoticeCookiesToDelete":[],"wgCentralNoticeCategoriesUsingLegacy":["Fundraising","fundraising"],"wgWikibaseItemId":"Q17149636","wgCentralAuthMobileDomain":false,"wgEditSubmitButtonLabelPublish":true});mw.loader.state({"ext.gadget.charinsert-styles":"ready","ext.globalCssJs.user.styles":"ready","ext.globalCssJs.site.styles":"ready","site.styles":"ready","noscript":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","ext.globalCssJs.site":"ready","user":"ready","user.options":"ready","user.tokens":"loading","ext.cite.styles":"ready","mediawiki.legacy.shared":"ready","mediawiki.legacy.commonPrint":"ready","jquery.makeCollapsible.styles":"ready","mediawiki.toc.styles":"ready","wikibase.client.init":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready","ext.3d.styles":"ready","mediawiki.skinning.interface":"ready","skins.vector.styles":"ready"});mw.loader.implement("user.tokens@0tffind",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.startup","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.watchlist-notice","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.eventlogger","ext.uls.init","ext.uls.compactlinks","ext.uls.interface","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp","skins.vector.js"];mw.loader.load(RLPAGEMODULES);});</script>
<link href="/w/load.php?lang=en&amp;modules=ext.3d.styles%7Cext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.skinning.interface%7Cmediawiki.toc.styles%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector"></script>
<meta content="" name="ResourceLoaderDynamicStyles"/>
<link href="/w/load.php?lang=en&amp;modules=ext.gadget.charinsert-styles&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<link href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<meta content="MediaWiki 1.34.0-wmf.1" name="generator"/>
<meta content="origin" name="referrer"/>
<meta content="origin-when-crossorigin" name="referrer"/>
<meta content="origin-when-cross-origin" name="referrer"/>
<link href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/NK-92" rel="alternate"/>
<link href="/w/index.php?title=NK-92&amp;action=edit" rel="alternate" title="Edit this page" type="application/x-wiki"/>
<link href="/w/index.php?title=NK-92&amp;action=edit" rel="edit" title="Edit this page"/>
<link href="/static/apple-touch/wikipedia.png" rel="apple-touch-icon"/>
<link href="/static/favicon/wikipedia.ico" rel="shortcut icon"/>
<link href="/w/opensearch_desc.php" rel="search" title="Wikipedia (en)" type="application/opensearchdescription+xml"/>
<link href="//en.wikipedia.org/w/api.php?action=rsd" rel="EditURI" type="application/rsd+xml"/>
<link href="//creativecommons.org/licenses/by-sa/3.0/" rel="license"/>
<link href="//en.wikipedia.org/wiki/NK-92" rel="canonical"/>
<link href="//login.wikimedia.org" rel="dns-prefetch"/>
<link href="//meta.wikimedia.org" rel="dns-prefetch"/>
<!--[if lt IE 9]><script src="/w/load.php?lang=qqx&amp;modules=html5shiv&amp;only=scripts&amp;skin=fallback&amp;sync=1"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-NK-92 rootpage-NK-92 skin-vector action-view">
<div class="noprint" id="mw-page-base"></div>
<div class="noprint" id="mw-head-base"></div>
<div class="mw-body" id="content" role="main">

<div class="mw-body-content" id="siteNotice"><!-- CentralNotice --></div>
<div class="mw-indicators mw-body-content">
</div>
<h1 class="firstHeading" id="firstHeading" lang="en">NK-92</h1>
<div class="mw-body-content" id="bodyContent">
<div class="noprint" id="siteSub">From Wikipedia, the free encyclopedia</div>
<div id="contentSub"></div>
<div id="jump-to-nav"></div>
Jump to navigation
Jump to search
<div class="mw-content-ltr" dir="ltr" id="mw-content-text" lang="en"><div class="mw-parser-output"><table class="box-Multiple_issues plainlinks metadata ambox ambox-content ambox-multiple_issues compact-ambox" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="" data-file-height="40" data-file-width="40" decoding="async" height="40" src="https://upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png" srcset width="40"/></div></td><td class="mbox-text"><div class="mbox-text-span"><div class="mw-collapsible" style="width:95%; margin: 0.2em 0;"><b>This article has multiple issues.</b> Please help <b>improve it</b> or discuss these issues on the <b>talk page</b>. <small><i>(Learn how and when to remove these template messages)</i></small>
<div class="mw-collapsible-content" style="margin-top: 0.3em;">
<table class="box-Original_research plainlinks metadata ambox ambox-content ambox-Original_research" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="" data-file-height="40" data-file-width="40" decoding="async" height="40" src="https://upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png" srcset width="40"/></div></td><td class="mbox-text"><div class="mbox-text-span">This article  <b>possibly contains original research</b>.<span class="hide-when-compact"> Please improve it by verifying the claims made and adding inline citations. Statements consisting only of original research should be removed.</span> <small class="date-container"><i>(<span class="date">April 2013</span>)</i></small><small class="hide-when-compact"><i> (Learn how and when to remove this template message)</i></small></div></td></tr></tbody></table>
<table class="box-More_footnotes plainlinks metadata ambox ambox-style ambox-More_footnotes" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="" data-file-height="48" data-file-width="48" decoding="async" height="40" src="https://upload.wikimedia.org/wikipedia/commons/thumb/a/a4/Text_document_with_red_question_mark.svg/40px-Text_document_with_red_question_mark.svg.png" srcset width="40"/></div></td><td class="mbox-text"><div class="mbox-text-span">This article includes a list of references, but <b>its sources remain unclear</b> because it has <b>insufficient inline citations</b>.<span class="hide-when-compact"> Please help to improve this article by introducing more precise citations.</span> <small class="date-container"><i>(<span class="date">April 2013</span>)</i></small><small class="hide-when-compact"><i> (Learn how and when to remove this template message)</i></small></div></td></tr></tbody></table>
<table class="box-Advert plainlinks metadata ambox ambox-content ambox-Advert" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="" data-file-height="40" data-file-width="40" decoding="async" height="40" src="https://upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png" srcset width="40"/></div></td><td class="mbox-text"><div class="mbox-text-span">This article <b>contains content that is written like an advertisement</b>.<span class="hide-when-compact"> Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view.</span> <small class="date-container"><i>(<span class="date">April 2013</span>)</i></small><small class="hide-when-compact"><i> (Learn how and when to remove this template message)</i></small></div></td></tr></tbody></table>
<table class="box-COI plainlinks metadata ambox ambox-content ambox-COI" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="Unbalanced scales.svg" data-file-height="354" data-file-width="400" decoding="async" height="40" src="https://upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Unbalanced_scales.svg/45px-Unbalanced_scales.svg.png" srcset width="45"/></div></td><td class="mbox-text"><div class="mbox-text-span"><b> A major contributor to this article appears to have a close connection with its subject.</b><span class="hide-when-compact"> It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page.</span> <small class="date-container"><i>(<span class="date">April 2013</span>)</i></small><small class="hide-when-compact"><i> (Learn how and when to remove this template message)</i></small></div></td></tr></tbody></table>
</div>
</div><small class="hide-when-compact"><i> (Learn how and when to remove this template message)</i></small></div></td></tr></tbody></table>
<p>NK-92 is an immortal cell line that has features and characteristics of natural killer (NK) cells that every person has circulating in the blood.Â Blood NK cells and NK-92 cells recognize invaders such as viruses and fungi. NK-92 cells, like blood NK cells, can attack cancer cells if the tumor has not grown out of control. NK-92 cells were isolated and characterized by the laboratory of Hans Klingemann at the British Columbia Cancer Agency in Vancouver, Canada. The cells came from a patient who had a NK cell lymphoma, a rare lymphoma type. Although several other NK cell lines have been cloned, only NK-92 cells can be expanded to larger numbers and consistently kill tumor cells. When NK-92 cells bind to a cancer or infected cell, they secrete perforin, which punches holes in target cells, followed by granzymes, which induce apoptosis in the target cells. NK-92 cells also attack cancer cells through the Fas-Fas ligand system and are capable of producing cytokines that by themselves can kill cancer cells (such as TNF-alpha) or stimulate and expand other immune cells such as interferon.
<span style="border: 3px solid blue; color:blue;font-weight: bold">1</span></p>
<div class="toc" id="toc"><input class="toctogglecheckbox" id="toctogglecheckbox" role="button" style="display:none" type="checkbox"/><div class="toctitle" dir="ltr" lang="en"><h2>Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><span class="tocnumber">1</span> <span class="toctext">Licensing</span></li>
<li class="toclevel-1 tocsection-2"><span class="tocnumber">2</span> <span class="toctext">In clinical trials</span></li>
<li class="toclevel-1 tocsection-3"><span class="tocnumber">3</span> <span class="toctext">Genetic engineering</span></li>
<li class="toclevel-1 tocsection-4"><span class="tocnumber">4</span> <span class="toctext">References</span></li>
<li class="toclevel-1 tocsection-5"><span class="tocnumber">5</span> <span class="toctext">External links</span></li>
</ul>
</div>
<h2><span class="mw-headline" id="Licensing">Licensing</span></h2>
<p>The cell line has been licensed to NantKwest and is currently being developed in the clinic for intravenous therapy in hematological malignancies and solid tumors, for local intra-tumor injection, as effector cells for antibody-mediated killing via CD16 modified cells and as effector cells for chimeric antigen receptor (CAR) specific killing. The cell line has been licensed for non-clinical applications to Brink Biologics and for veterinary applications to Coneksis.
<span style="border: 3px solid blue; color:blue;font-weight: bold">2</span></p><p>NantKwest's authorized distributor is Brink Biologics, which makes NK-92 cells and certain genetically modified variants available for laboratory assays and in vivo research, including ADCC assays that quantify the contribution of ADCC in the therapeutic effect of monoclonal antibodies (Brink Biologics' Neukopanel) and for other non-clinical assay applications.
<span style="border: 3px solid blue; color:blue;font-weight: bold">3</span></p>
<h2><span class="mw-headline" id="In_clinical_trials">In clinical trials</span></h2>
<p>Three phase I clinical trials, led by experts in adoptive immunotherapy of cancer, have so far yielded excellent results. Hans Klingemann and Sally Arai completed the US trial at Rush University Medical Center (Chicago) in renal cell and melanoma patients, and Torsten Tonn, MD and Oliver Ottmann, MD completed the European trial at the University of Frankfurt in patients with various solid and hematological malignancies. Armand Keating is completing the last cohort of patients in the Canadian trial at Princess Margaret Hospital in Toronto in lymphoma patients after autologous bone marrow transplants. In all three programs, NK-92 cells were administered as a simple intravenous infusion, dosed two or three times per treatment course and given in the outpatient setting.
<span style="border: 3px solid blue; color:blue;font-weight: bold">4</span></p><p>Most importantly, there were no grade â‰¥ 2 side-effects during or after the short infusion of NK-92 cells. The maximum dose given in the Frankfurt trial was 10e10 cells/me2 x 2 infusions, each 48 hours apart. The Chicago study infused NK-92 cells at a maximum of 5 x 10e cells/me2 x 3 infusions, each 48 hours apart. This was not the MTD but rather the number of cells that could be expanded in culture bags over a three-week culture period. Alternative cell expansion technologies (bioreactors) will make it possible to further expand the numbers of NK-92 cells on a smaller 'footprint'.   Anecdotal reports of antitumor activity in the two completed phase I studies have been observed in 6/11 patients with renal cancer, 3/4 patients with lung cancer, and 1/1 patient with melanoma, all with very advanced disease. In addition to disease stabilization and regression of metastases in lung and lymph nodes, the severe pain associated with tumor metastases in several patients, which had been refractory to standard chemotherapy, was remarkably lessened.  The ongoing trial in Toronto treats patients with lymphoma who have relapsed after an autologous stem cell transplant. Preliminary results suggest a significant benefit in several patients.
<span style="border: 3px solid blue; color:blue;font-weight: bold">5</span></p>
<h2><span class="mw-headline" id="Genetic_engineering">Genetic engineering</span></h2>
<p>NK-92 cells can be genetically engineered to recognize and kill human cancer cells. 
Chimeric Antigen Receptor (CAR) engineered T-lymphocytes are popular in immuno-oncology, having shown that infusion of those engineered cells can achieve remissions in some patients with acute and chronic leukemia. In contrast, NK cells (either from peripheral blood or cord blood) have not generated sufficient interest as CARâ€‘engineered cytotoxic effector cells because the extent of NK cell expansion can be dependent on the donor and because transfection efficiency, even with lentiviral or retroviral vectors, is only moderately efficient. NK-92 cells, on the other hand, have predictable expansion kinetics and can be grown in bioreactors to billions of cells within a couple of weeks. They can easily be transfected either with viral supernatant or physical methods. Even mRNA can be shuttled into the cells with high efficiency. Since no integration of mRNA into the genome occurs, this transfection is less risky.
<span style="border: 3px solid blue; color:blue;font-weight: bold">6</span></p><p>NK-92 cells have also been transfected with a high affinity Fc Receptor (NK-92Fc) which is the main receptor for monoclonal antibodies to execute antibody dependent cellular cytotoxicty (ADCC), including rituximab and ofatumumab. Based on this variant, an assay called Neukopanel has been developed to quantify the ADCC of monoclonal antibodies, a technology that has caught the attention of a number of biotech and pharmaceutical companies that use Neukopanel to determine the contribution of ADCC of their monoclonal antibodies.
<span style="border: 3px solid blue; color:blue;font-weight: bold">7</span></p>
<h2><span class="mw-headline" id="References">References</span></h2>
<div class="reflist" style="list-style-type: decimal;">
<div class="mw-references-wrap"><ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text">Arai S, Meagher R, Swearingen M, et al. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial. Cytotherapy 2008;10:625-32</span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text">Tonn T, Becker S, Esser R, Schwabe D, Seifried E. Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92. J Hematother Stem Cell Res 2001;10:535-44.</span>
</li>
<li id="cite_note-pmid21830940-3"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Porter DL, Levine BL, Kalos M, Bagg A, June CH (August  2011). "Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia". <i>N. Engl. J. Med</i>. <b>365</b> (8): 725â€“33. doi:10.1056/NEJMoa1103849. PMCÂ <span class="cs1-lock-free" title="Freely accessible">3387277</span>. PMIDÂ 21830940.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.atitle=Chimeric+antigen+receptor-modified+T+cells+in+chronic+lymphoid+leukemia&amp;rft.volume=365&amp;rft.issue=8&amp;rft.pages=725-33&amp;rft.date=2011-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3387277&amp;rft_id=info%3Apmid%2F21830940&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1103849&amp;rft.aulast=Porter&amp;rft.aufirst=DL&amp;rft.au=Levine%2C+BL&amp;rft.au=Kalos%2C+M&amp;rft.au=Bagg%2C+A&amp;rft.au=June%2C+CH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3387277&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANK-92"></span><style data-mw-deduplicate="TemplateStyles:r886058088">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-pmid19562616-4"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Weitzman J, Betancur M, Boissel L, Rabinowitz AP, Klein A, Klingemann H (August  2009). "Variable contribution of monoclonal antibodies to ADCC in patients with chronic lymphocytic leukemia". <i>Leuk. Lymphoma</i>. <b>50</b> (8): 1361â€“8. doi:10.1080/10428190903026500. PMIDÂ 19562616.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Leuk.+Lymphoma&amp;rft.atitle=Variable+contribution+of+monoclonal+antibodies+to+ADCC+in+patients+with+chronic+lymphocytic+leukemia&amp;rft.volume=50&amp;rft.issue=8&amp;rft.pages=1361-8&amp;rft.date=2009-08&amp;rft_id=info%3Adoi%2F10.1080%2F10428190903026500&amp;rft_id=info%3Apmid%2F19562616&amp;rft.aulast=Weitzman&amp;rft.aufirst=J&amp;rft.au=Betancur%2C+M&amp;rft.au=Boissel%2C+L&amp;rft.au=Rabinowitz%2C+AP&amp;rft.au=Klein%2C+A&amp;rft.au=Klingemann%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANK-92"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="External_links">External links</span></h2>
<ul><li>Cellosaurus entry for NK-92 Cells</li></ul>
<!-- 
NewPP limit report
Parsed by mw1320
Cached time: 20190423181523
Cache expiry: 2592000
Dynamic content: false
CPU time usage: 0.260 seconds
Real time usage: 0.367 seconds
Preprocessor visited node count: 1092/1000000
Preprocessor generated node count: 0/1500000
Postâ€expand include size: 59110/2097152 bytes
Template argument size: 14789/2097152 bytes
Highest expansion depth: 17/40
Expensive parser function count: 10/500
Unstrip recursion depth: 1/20
Unstrip postâ€expand size: 7945/5000000 bytes
Number of Wikibase entities loaded: 2/400
Lua time usage: 0.158/10.000 seconds
Lua memory usage: 2.93 MB/50 MB
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  326.219      1 -total
 43.52%  141.976      1 Template:Reflist
 40.76%  132.961      2 Template:Cite_journal
 38.44%  125.402      5 Template:Ambox
 34.08%  111.183      1 Template:Multiple_issues
 15.58%   50.832      4 Template:Fix
 12.21%   39.847      2 Template:Fact
  7.95%   25.948      1 Template:Original_research
  7.78%   25.366      4 Template:Delink
  6.34%   20.684      1 Template:More_footnotes
-->
<!-- Saved in parser cache with key enwiki:pcache:idhash:39124671-0!canonical and timestamp 20190423181522 and revision id 890886148
 -->
</div><noscript><img alt="" height="1" src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" srcset style="border: none; position: absolute;" title="" width="1"/></noscript></div>
<div class="printfooter">Retrieved from "//en.wikipedia.org/w/index.php?title=NK-92&amp;oldid=890886148"</div>
<div class="catlinks" data-mw="interface" id="catlinks"><div class="mw-normal-catlinks" id="mw-normal-catlinks">Categories: <ul><li>Human cell lines</li><li>Cancer treatments</li><li>Biotechnology</li><li>Genetic engineering</li></ul></div><div class="mw-hidden-catlinks mw-hidden-cats-hidden" id="mw-hidden-catlinks">Hidden categories: <ul><li>Articles that may contain original research from April 2013</li><li>All articles that may contain original research</li><li>Articles lacking in-text citations from April 2013</li><li>All articles lacking in-text citations</li><li>Articles with a promotional tone from April 2013</li><li>All articles with a promotional tone</li><li>Wikipedia articles with possible conflicts of interest from April 2013</li><li>Articles with multiple maintenance issues</li><li>All articles with unsourced statements</li><li>Articles with unsourced statements from April 2019</li><li>All articles with vague or ambiguous time</li><li>Vague or ambiguous time from March 2019</li><li>Articles with unsourced statements from March 2019</li><li>All articles with specifically marked weasel-worded phrases</li><li>Articles with specifically marked weasel-worded phrases from March 2019</li></ul></div></div>
<div class="visualClear"></div>
</div>
</div>

<div id="footer" role="contentinfo">
<ul id="footer-info">
<li id="footer-info-lastmod"> This page was last edited on 4 April 2019, at 05:42<span class="anonymous-show">Â (UTC)</span>.</li>
<li id="footer-info-copyright">Text is available under the Creative Commons Attribution-ShareAlike License;
additional terms may apply.  By using this site, you agree to the Terms of Use and Privacy Policy. WikipediaÂ® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.</li>
</ul>
<ul id="footer-places">
<li id="footer-places-privacy">Privacy policy</li>
<li id="footer-places-about">About Wikipedia</li>
<li id="footer-places-disclaimer">Disclaimers</li>
<li id="footer-places-contact">Contact Wikipedia</li>
<li id="footer-places-developers">Developers</li>
<li id="footer-places-cookiestatement">Cookie statement</li>
<li id="footer-places-mobileview">Mobile view</li>
</ul>
<ul class="noprint" id="footer-icons">
<li id="footer-copyrightico">
<img alt="Wikimedia Foundation" height="31" src="/static/images/wikimedia-button.png" srcset width="88"/> </li>
<li id="footer-poweredbyico">
<img alt="Powered by MediaWiki" height="31" src="/static/images/poweredby_mediawiki_88x31.png" srcset width="88"/> </li>
</ul>
<div style="clear: both;"></div>
</div>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.260","walltime":"0.367","ppvisitednodes":{"value":1092,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":59110,"limit":2097152},"templateargumentsize":{"value":14789,"limit":2097152},"expansiondepth":{"value":17,"limit":40},"expensivefunctioncount":{"value":10,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":7945,"limit":5000000},"entityaccesscount":{"value":2,"limit":400},"timingprofile":["100.00%  326.219      1 -total"," 43.52%  141.976      1 Template:Reflist"," 40.76%  132.961      2 Template:Cite_journal"," 38.44%  125.402      5 Template:Ambox"," 34.08%  111.183      1 Template:Multiple_issues"," 15.58%   50.832      4 Template:Fix"," 12.21%   39.847      2 Template:Fact","  7.95%   25.948      1 Template:Original_research","  7.78%   25.366      4 Template:Delink","  6.34%   20.684      1 Template:More_footnotes"]},"scribunto":{"limitreport-timeusage":{"value":"0.158","limit":"10.000"},"limitreport-memusage":{"value":3068813,"limit":52428800}},"cachereport":{"origin":"mw1320","timestamp":"20190423181523","ttl":2592000,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"\/\/schema.org","@type":"Article","name":"NK-92","url":"\/\/en.wikipedia.org\/wiki\/NK-92","sameAs":"http:\/\/www.wikidata.org\/entity\/Q17149636","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q17149636","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2013-04-16T02:35:04Z","dateModified":"2019-04-04T05:42:29Z","headline":"cell line"}</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":100,"wgHostname":"mw1325"});});</script>
</body>
</html>
<script>function offsetAnchor() {if(location.hash.length !== 0) {window.scrollTo(window.scrollX, window.scrollY - 250);}}window.addEventListener("hashchange", offsetAnchor);window.setTimeout(offsetAnchor, 1);</script>